Back to ADCT
TCG Crossover Management, LLC → ADCT
TCG Crossover Management, LLC ADCT Position History
ADC Therapeutics SA • Healthcare
Quarters held
4
Latest value
$13.9M
Q3 2026
Peak value
$42.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $40.2M |
| Q1 2026 | $42.7M |
| Q2 2026 | $12.2M |
| Q3 2026 | $13.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $13.9M | 11.39M | — | — |
| Q2 2026 | $12.2M | 11.39M | — | — |
| Q1 2026 | $42.7M | 11.39M | — | — |
| Q4 2025 | $40.2M | 11.39M | — | — |
Other funds holding ADCT
$91.8M
$55.3M
$50M
$31.3M
$31.1M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC